{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:26:24Z","timestamp":1780824384271,"version":"3.54.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BayBIO","award":["FKZ BIO-1505-0004"],"award-info":[{"award-number":["FKZ BIO-1505-0004"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.omtn.2019.04.018","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:20:07Z","timestamp":1556238007000},"page":"686-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In\u00a0Vitro"],"prefix":"10.1016","volume":"16","author":[{"given":"Anne","family":"Sadewasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Dietzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kl\u00fcver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Helfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Thelemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Eickmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jaschinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.04.018_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nri1154","article-title":"Ebola virus: from discovery to vaccine","volume":"3","author":"Feldmann","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"12, Suppl","key":"10.1016\/j.omtn.2019.04.018_bib2","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.04.018_bib3","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-010-0814-x","article-title":"Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations","volume":"155","author":"Kuhn","year":"2010","journal-title":"Arch. Virol."},{"key":"10.1016\/j.omtn.2019.04.018_bib4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.omtn.2019.04.018_bib5","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0140-6736(95)92841-3","article-title":"Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory","volume":"346","author":"Jaax","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2019.04.018_bib6","first-page":"227","article-title":"Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus","volume":"76","author":"Johnson","year":"1995","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.omtn.2019.04.018_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.04.018_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10409230802058320","article-title":"Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme","volume":"43","author":"White","year":"2008","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.omtn.2019.04.018_bib9","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/cdd.2015.67","article-title":"Molecular mechanisms of Ebola virus pathogenesis: focus on cell death","volume":"22","author":"Falasca","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omtn.2019.04.018_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.04.018_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.04.018_bib12","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3390\/v4112471","article-title":"Niemann-Pick C1 (NPC1)\/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor","volume":"4","author":"Krishnan","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2019.04.018_bib13","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/emboj.2012.53","article-title":"Ebola virus entry requires the host-programmed recognition of an intracellular receptor","volume":"31","author":"Miller","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2019.04.018_bib14","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1074\/jbc.275.6.4013","article-title":"Role of Niemann-Pick type C1 protein in intracellular trafficking of low density lipoprotein-derived cholesterol","volume":"275","author":"Cruz","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2019.04.018_bib15","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1073\/pnas.0807328105","article-title":"NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes","volume":"105","author":"Infante","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.04.018_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.277.5323.228","article-title":"Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis","volume":"277","author":"Carstea","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.omtn.2019.04.018_bib17","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1126\/science.290.5500.2298","article-title":"Identification of HE1 as the second gene of Niemann-Pick C disease","volume":"290","author":"Naureckiene","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.omtn.2019.04.018_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00565-15","article-title":"Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in\u00a0vivo","volume":"6","author":"Herbert","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.omtn.2019.04.018_bib19","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2019.04.018_bib20","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2019.04.018_bib21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cpdd.318","article-title":"Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers","volume":"6","author":"Schluep","year":"2017","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.omtn.2019.04.018_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0939-6411(02)00060-7","article-title":"Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides","volume":"54","author":"Dias","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.omtn.2019.04.018_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/nat.2014.0506","article-title":"Phosphorothioates, essential components of therapeutic oligonucleotides","volume":"24","author":"Eckstein","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2019.04.018_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drudis.2017.09.018","article-title":"Locked nucleic acid: modality, diversity, and drug discovery","volume":"23","author":"Hagedorn","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omtn.2019.04.018_bib25","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2174\/138161208784246234","article-title":"Locked nucleic acid holds promise in the treatment of cancer","volume":"14","author":"Frieden","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.omtn.2019.04.018_bib26","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/nar\/gkp841","article-title":"Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents","volume":"38","author":"Stein","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.04.018_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4939-2727-2_9","article-title":"Design and Selection of Antisense Oligonucleotides Targeting Transforming Growth Factor Beta (TGF-\u03b2) Isoform mRNAs for the Treatment of Solid Tumors","volume":"1317","author":"Jaschinski","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2019.04.018_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/154545704322988021","article-title":"Modulation of CpG Oligodeoxynucleotide-Mediated Immune Stimulation by Locked Nucleic Acid","volume":"14","author":"Vollmer","year":"2004","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.omtn.2019.04.018_bib29","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2019.04.018_bib30","doi-asserted-by":"crossref","first-page":"e71057","DOI":"10.1371\/journal.pone.0071057","article-title":"A human in\u00a0vitro whole blood assay to predict the systemic cytokine response to therapeutic oligonucleotides including siRNA","volume":"8","author":"Coch","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.04.018_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/07357900701681608","article-title":"Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients","volume":"26","author":"Ren","year":"2008","journal-title":"Cancer Invest."},{"issue":"Suppl 3","key":"10.1016\/j.omtn.2019.04.018_bib32","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1093\/infdis\/jiw254","article-title":"Ebola Virus Shedding and Transmission: Review of Current Evidence","volume":"214","author":"Vetter","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2019.04.018_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.antiviral.2018.06.003","article-title":"Identification of a small molecule inhibitor of Ebola virus genome replication and transcription using in\u00a0silico screening","volume":"156","author":"Easton","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2019.04.018_bib34","first-page":"81","article-title":".","volume":"2","author":"Kadanali","year":"2015"},{"key":"10.1016\/j.omtn.2019.04.018_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00005-0","article-title":"Experimental therapy of filovirus infections","volume":"54","author":"Bray","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2019.04.018_bib36","first-page":"823","article-title":"Therapy and prophylaxis of Ebola virus infections","volume":"6","author":"Feldmann","year":"2005","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.omtn.2019.04.018_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/17460794.2.2.205","article-title":"Filovirus replication and transcription","volume":"2","author":"M\u00fchlberger","year":"2007","journal-title":"Future Virol."},{"key":"10.1016\/j.omtn.2019.04.018_bib38","series-title":"Oligonucleotide-Based Drugs and Therapeutics","first-page":"191","article-title":"Hybridization-Dependent Effects:\u00a0The Prediction, Evaluation, and Consequences of Unintended Target Hybridization","author":"Kitson","year":"2018"},{"key":"10.1016\/j.omtn.2019.04.018_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/nat.2016.0656","article-title":"Molecular Mechanisms of Antisense Oligonucleotides","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2019.04.018_bib40","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.1093\/nar\/gkv964","article-title":"A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells","volume":"43","author":"Castanotto","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.04.018_bib41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrd3825","article-title":"Nuclear RNA more susceptible to knockdown: Antisense therapeutics","volume":"11","author":"Tse","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2019.04.018_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/nat.2018.0722","article-title":"Development of Locked Nucleic Acid Antisense Oligonucleotides Targeting Ebola Viral Proteins and Host Factor Niemann-Pick C1","volume":"28","author":"Chery","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2019.04.018_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/id500025n","article-title":"Chemical and Structural Aspects of Ebola Virus Entry Inhibitors","volume":"1","author":"Nyakatura","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.omtn.2019.04.018_bib44","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1074\/jbc.M112.412460","article-title":"Role of cathepsin D in U18666A-induced neuronal cell death: potential implication in Niemann-Pick type C disease pathogenesis","volume":"288","author":"Amritraj","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2019.04.018_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.omtn.2017.11.004","article-title":"A Sensitive In\u00a0Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides","volume":"10","author":"Dieckmann","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.04.018_bib46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2019.04.018_bib47","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ymthe.2017.03.023","article-title":"FDA-Approved Oligonucleotide Therapies in 2017","volume":"25","author":"Stein","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.04.018_bib48","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","article-title":"Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.04.018_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/nat.2018.0727","article-title":"Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don\u2019t","volume":"28","author":"Juliano","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2019.04.018_bib50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2019.04.018_bib51","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nbt.2376","article-title":"Assessing unintended hybridization-induced biological effects of oligonucleotides","volume":"30","author":"Lindow","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2019.04.018_bib52","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.omtn.2018.02.005","article-title":"Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In\u00a0Vivo","volume":"11","author":"Javanbakht","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.04.018_bib53","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/0006-2952(93)90014-N","article-title":"Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1","volume":"45","author":"Branda","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omtn.2019.04.018_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0024-3205(94)00780-2","article-title":"Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus","volume":"54","author":"Pisetsky","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.omtn.2019.04.018_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-2952(95)02177-9","article-title":"Effect of different chemically modified oligodeoxynucleotides on immune stimulation","volume":"51","author":"Zhao","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omtn.2019.04.018_bib56","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1073\/pnas.94.20.10833","article-title":"Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization","volume":"94","author":"Weiner","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.04.018_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2017.08.005","article-title":"Identification of new CpG oligodeoxynucleotide motifs that induce expression of interleukin-1\u03b2 and nitric oxide in avian macrophages","volume":"192","author":"Sanjaya","year":"2017","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.omtn.2019.04.018_bib58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2567.2004.01962.x","article-title":"Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation","volume":"113","author":"Vollmer","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.omtn.2019.04.018_bib59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4049\/jimmunol.174.2.605","article-title":"Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides","volume":"174","author":"Roberts","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2019.04.018_bib60","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.04.018_bib61","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.coi.2008.07.007","article-title":"Accessing the therapeutic potential of immunostimulatory nucleic acids","volume":"20","author":"Barchet","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.omtn.2019.04.018_bib62","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.04.018_bib63","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtn.2019.04.018_bib64","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects.","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omtn.2019.04.018_bib65","first-page":"204","article-title":"Recent advances in the development of immunostimulatory oligonucleotides","volume":"6","author":"Uhlmann","year":"2003","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.omtn.2019.04.018_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00179-17","article-title":"Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages","volume":"91","author":"Olejnik","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2019.04.018_bib67","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2019.04.018_bib68","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The Pathogenesis of Ebola Virus Disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol."},{"issue":"Suppl 2","key":"10.1016\/j.omtn.2019.04.018_bib69","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1093\/infdis\/jiv140","article-title":"Analysis of Ebola Virus Entry Into Macrophages","volume":"212","author":"Dahlmann","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2019.04.018_bib70","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0021-9673(01)93098-5","article-title":"Analytical study of phosphorothioate analogues of oligodeoxynucleotides using high-performance liquid chromatography","volume":"509","author":"Agrawal","year":"1990","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.omtn.2019.04.018_bib71","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.50.4.1393-1401.2006","article-title":"Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation","volume":"50","author":"Vaillant","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2019.04.018_bib72","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2016.07.004","article-title":"Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection","volume":"133","author":"Vaillant","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2019.04.018_bib73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0928-0987(00)00208-6","article-title":"Antisense therapy of influenza","volume":"13","author":"Abe","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.omtn.2019.04.018_bib74","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/135965350701200810","article-title":"Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression","volume":"12","author":"Guzman","year":"2007","journal-title":"Antivir. Ther. (Lond.)"},{"key":"10.1016\/j.omtn.2019.04.018_bib75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virol.2007.10.016","article-title":"Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers","volume":"372","author":"Lee","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2019.04.018_bib76","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/AAC.00279-08","article-title":"Amphipathic DNA polymers exhibit antiherpetic activity in\u00a0vitro and in\u00a0vivo","volume":"52","author":"Bernstein","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2019.04.018_bib77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1743-422X-6-214","article-title":"Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection","volume":"6","author":"Cardin","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.omtn.2019.04.018_bib78","doi-asserted-by":"crossref","first-page":"46374","DOI":"10.1038\/srep46374","article-title":"Structure of the Ebola virus glycoprotein spike within the virion envelope at 11\u2009\u00c5 resolution","volume":"7","author":"Beniac","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2019.04.018_bib79","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/bioinformatics\/btn223","article-title":"PatMaN: rapid alignment of short sequences to large databases","volume":"24","author":"Pr\u00fcfer","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2019.04.018_bib80","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1093\/nar\/gkg580","article-title":"OligoDesign: Optimal design of LNA (locked nucleic acid) oligonucleotide capture probes for gene expression profiling","volume":"31","author":"Tolstrup","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.04.018_bib81","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1093\/nar\/gku142","article-title":"Sequence motifs associated with hepatotoxicity of locked nucleic acid: modified antisense oligonucleotides","volume":"42","author":"Burdick","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.04.018_bib82","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1128\/JCM.39.11.4125-4130.2001","article-title":"Development and evaluation of a fluorogenic 5\u2032 nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan","volume":"39","author":"Gibb","year":"2001","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.omtn.2019.04.018_bib83","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119300915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119300915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T15:34:36Z","timestamp":1717688076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253119300915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":83,"alternative-id":["S2162253119300915"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.04.018","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In\u00a0Vitro","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}